In re Lidoderm Antitrust Litigation (N.D. Cal.)

TCL played a key role on the Executive Committee guiding this case on behalf of purchasers of Lidoderm alleging that the defendants conspired to delay launch of
less expensive versions of lidocaine patches. Along with our co-counsel, we recovered a $166 million settlement for direct purchasers on the eve of trial.

Scroll to Top